International Society for the Study of Women's Sexual Health

NEWS

FDA announced a Public Advisory Committee Meeting

FDA announced a Public Advisory Committee Meeting to review the approval of flibanserin for hypoactive sexual desire disorder (HSDD) in women on June 4, 2015. Should you wish to submit your written comments or request time at the public microphone, the deadline is a week away. Please find all details in the Federal Register Notice by clicking on this link. - -

Save the Date


ISSWSH Fall Course 2017

  November 2-4, 2017  77 days left
  DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...


ISSWSH Annual Meeting 2018

  February 8-11, 2018  175 days left
  Hilton San Diego on Mission Bay
San Diego, CA, USA

Read more...

Latest Tweets

RT @jsexmed: Female urinary incontinence adversly affects #sexualfunction @NeurourolUrodyn https://t.co/gAlMPptYZu ISSWSH
RT @jsexmed: Does Practice Make Perfect? Sexual Experience and Psychomotor Stimulants Influence Female Sexual Motivation https://t.co/T2dtl… ISSWSH
RT @jsexmed: Genital self-image should be assessed in women with pelvic floor disorders due to its high impact on sexual function https://t… ISSWSH

Contact Details

ISSWSH Executive Office
PO Box 1233
Lakeville, MN 55044
USA

Phone: +1 (952) 683 9025
Fax: +1 (612) 808 0491
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.